24 2 25 Author contributions: 26 V.M.S., X.C., and D.J.Z. conceived the study. V.M.S. and X.C. contributed to reagent 27 generation, data acquisition and interpretation, and manuscript preparation. C.W. generated the 28 EP1 hiPSC RGC reporter line. Y.D. contributed to reagent generation. V.M.S. wrote the 29 manuscript with contributions from all other authors. 30 31 Abstract: 35 Pluripotent stem cells (PSCs) edited with genetic reporters are useful tools for 36 differentiation analysis and for isolation of specific cell populations for study. Reporter 37 integration into the genome is now commonly achieved by targeted DNA nuclease-enhanced 38 homology directed repair (HDR). However, human PSCs are known to have a low frequency of 39 gene knock-in (KI) by HDR, making reporter line generation an arduous process. Here, we 40 report a methodology for scarless KI of large fluorescent reporter genes into PSCs by transient 41 selection with puromycin or zeocin. With this method, we can perform targeted KI of a single 42
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efficiency for the different lines was noted, transient puromycin selection yielded a 5 to 24-fold 141 increase in KI frequencies for all hESC and hiPSC lines tested (Fig 3) . Then to test KI for a gene 142 that is not expressed in undifferentiated stem cells, since chromatin state associated with 143 transcriptional activity could potentially affect HDR efficiency, we transfected EP1 hiPSCs with 144 the BRN3B (POU4F2)-P2A-tdTomato-P2A-Thy1.2 construct that we previously used to make 145 retinal ganglion cell (RGC) reporter lines in H7 and H9 hESCs(11). Following transfection and 146 transient puromycin selection, we plated the surviving cells as single cells at a low density for 147 clonal derivation. PCR-based genotyping of 65 individual clones showed a markedly increased 148 KI efficiency of 64.6% (Fig 4) , compared to our initial frequency of 1.4% using traditional 149 methodology with this same reporter construct(11). Karyotyping and PCR-based off-target 150 analysis of the EP1-derived BRN3B reporter line showed that the puromycin treatment did not 151 cause chromosomal abnormalities or off-target editing (S1 Fig)(12) . Additionally, we 152 differentiated the EP1 reporter line to RGCs per our prior protocol(11), and observed no 153 differences in our ability to derive RGCs from this reporter line generated using transient 154 puromycin selection. Untransfected cells were used to set the gates for reporter negative cells. n = 2 for both groups. and IMR90-4 hiPSC lines, respectively, with and without transient puromycin selection. For EP1 and H7, n = 2 for both groups, for IMR90-4 n = 3 for replicates without puromycin and n = 4 for 164 replicates with puromycin treatment. n = biological replicates. p values: EP1 = 0.0246, H7 = 165 0.1532, IMR90-4 = <0.0001. * = p<.05, ** = p<.01, **** = p<.0001. ns = not significant.
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Unpaired two tailed t-test was used. 
Transient puromycin selection allows for the creation of dual reporter KI lines
Based on the ability of puromycin transient selection to promote generation of single 186 reporter KI lines, we evaluated its ability to promote simultaneous KI of two reporters in two 187 different loci. For this experiment, we targeted a KI of TBP-P2A-eGFP and MYC-P2A-tdTomato 188 or TBP-P2A-tdTomato and SOX2-P2A-eGFP into H9 hESCs and analyzed the result by flow 189 cytometry. With puromycin selection, KI frequencies were ~9.5% and 11.3% for each 190 combination, respectively ( Fig 5) . Notably, most of our KI cells were double positive, supporting 191 the previously reported observation that HDR occurrence at one locus is associated with an 192 increased frequency of HDR at other loci(30, 31). Given that all the above-described experiments were performed with human PSCs, we 203 wanted to test if transient puromycin selection would also promote HDR in mouse stem cells.
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After establishing an appropriate puromycin dose for the commonly used mouse embryonic stem 205 cell (mESC) line E14TG2a(32), we transfected these cells via lipofection with CRISPR plasmids 206 and the corresponding donor templates for AdipoR1-eGFP, Mitf-P2A-tagRFP, and Six6-P2A-207 GFP, targeting the genes for the adiponectin receptor 1, melanogenesis associated transcription factor, and sine oculis-related homeobox 6, respectively. Due to their faster growth rate, we 209 treated the mESCs with puromycin at 24 hours post transfection rather than the 40 hours that was 210 used for human PSCs. Following recovery, the surviving populations were plated as single cells 211 to derive independent colonies and 24 colonies were PCR-screened for KI insertion. We found 212 KI frequencies of 45.8%, 33.3%, and 58.3% for targeting AdipoR1, Mitf, and Six6, respectively 213 ( Fig 6) . To check whether puromycin treatment had abrogated the ability of these cells to 214 faithfully differentiate, we tested one of the homozygous Six6-P2A-eGFP lines in optic cup 215 retinal differentiation(33). Six6 is an eye field transcription factor that is highly expressed in the Next, to test if the ability of transient puromycin selection to improve KI efficiency is 233 simply due to enrichment of transfected cells or through some other activity specific to 234 puromycin, we tested if treatment with another selective agent would increase KI efficiency to a 235 comparable extent. We replaced the puromycin resistance sequence in the Cas9 plasmid with one 236 for zeocin resistance (Cas9-P2A-Zeocin). Zeocin, which has a completely different mechanism 237 of action (targeting DNA) than puromycin (inhibiting protein translation), also results in rapid 238 death of untransfected stem cells(36). We repeated the KI experiments using Cas9-P2A-Zeocin 239 and the TBP-P2A-eGFP donor plasmids. Transient 24 hour zeocin selection at 40 hours post 240 transfection resulted in 13.7% and 9.2% KI efficiency for IMR90-4 hiPSCs and H7 hESCs, 241 respectively (Fig 7) , values that were actually slightly higher than our prior puromycin selection 242 efforts targeting TBP in these cell lines. 
Discussion:
Genome editing of pluripotent stem cells (PSCs) greatly enhances the utility of PSCs for 255 studying biological processes, use in disease modeling(9), and reporter line generation for 256 specific cell type isolation (11, 12) . Here, we have demonstrated that transient selection with 257 puromycin or zeocin can facilitate highly efficient scarless KI of relatively large reporter genes 258 (over 2 kb in the case of BRN3B-P2A-tdTomato-P2A-Thy1.2) into both human and mouse PSCs.
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These KI cell lines differentiated normally, and did not show karyotypic abnormalities or display 260 off-target effects. Moreover, since the antibiotic resistance gene is not integrated into the 261 genome, these reporter-positive clones could be directly expanded for use in experiments without 262 the need to undergo further manipulation to excise the resistance cassette. 263 We have successfully applied the transient selection method in four human PSC lines for 264 KI at four different loci as well as one mESC line with KI at three other loci. Our observed KI 265 efficiencies varied from 6.6 to 64.6% in human PSCs and from 33.3 to 58.3% in mESCs, 266 presumably reflecting the high degree of gene editing variability that has also been observed by 267 others (24, 25). Although mouse stem cells generally demonstrate higher KI frequencies than 268 their human counterparts (e.g. a previous study had reported a KI efficiency of 15% for insertion 269 of eGFP(37)), the KI frequencies we observed in mESCs were even higher than the ones 270 achieved via small molecules(18) or positive KI selection(31). With the high KI efficiencies 271 described in this manuscript, with both human and mouse PSCs, it becomes reasonable to isolate 272 reporter-positive lines from as few as approximately twenty clones versus the standard practice 273 of picking hundreds of clones. Moreover, we were able to generate dual KI reporter cell lines at 274~10% efficiency. A dual KI reporter could be advantageous to mark different cell subtypes(11), 275 label differentiation progression(38), or to increase stringency of selection in situations where a 276 single gene signature is not enough to define a specific cell population. Importantly, based on our data and the previous report that successful HDR at one locus is associated with increased 278 frequency of HDR at additional loci (30, 31) , it should be possible to multi-plex reporter KIs to 279 more than two loci. Additionally, with a high KI efficiency it may be advantageous to knock-out 280 genes by knocking-in stop codon sequences at precise locations instead of relying on NHEJ to 281 generate loss of function alleles by random mutagenesis.
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Recently, Steyer and Bu et al.(39) reported that transient puromycin selection for 3 283 consecutive days increased the efficiency of single base pair KI in human PSCs to values 284 between 14 to 44%. Notably, as KI efficiency tends to decrease with increasing insert size(40), 285 their reported KI frequency for a 21 base pair insert was a little lower at 36%, and they did not 286 demonstrate that their method could be used to KI larger constructs. In their method, human 287 PSCs are electroporated and puromycin is added for 3 days starting at 24 hours post transfection 288 along with a Rho kinase (ROCK) inhibitor. Our methodology utilizes lipofection and 289 puromycin/zeocin that was added at ~40 hours post transfection and for only 24 hours. Although 290 both our data and their work(39) suggest that puromycin treatment does not alter the karyotype 291 of PSCs, or increase off-target effects, decreasing the exposure of the cells to puromycin is likely 292 to reduce the possibility of undesired side-effects, as prolonged antibiotic exposure could 293 increase the risk of random integration of the resistance gene into the genome. 294 We wondered if the observed KI efficiency was increased due to a more robust selection 295 pressure that was enriching for the highest Cas9-P2A-Puro expressing cells or whether 296 puromycin itself had an effect on HDR. To explore this hypothesis we tested whether zeocin, an 297 antibiotic with a different mechanism of action from puromycin, would yield a comparable high 298 KI frequency to that which we had observed with puromycin, and found that it did. This result introduced to increase KI efficiency in PSCs. Guo et al.(41) have reported that a cold-shock of 305 hiPSCs achieved by decreasing the culture temperature to 32 °C for 24-48 hours following 306 transfection increased KI of small base pair inserts to 20-40%. However, this cold-shock 307 appeared to have a negative effect on NANOG expression, a potential sign of decreased 308 pluripotency. Notably, Zhang and Li et al.(42) introduced a method that could improve KI 309 efficiency for large constructs to 15-30% in hiPSCs. However, to generate this effect their 310 experimental workflow requires cell cycle synchronization via a co-transfection with a CCND1 311 plasmid and Nocodazole treatment in combination with a pre-designed donor vector containing 312 gRNA sites that enable donor template linearization inside the cell. Importantly, the effects of 313 these treatments on the karyotype, off-target mutations, and downstream differentiation were not 314 addressed in either study. It is possible that the combinatorial effect of cold-shocking or cell 315 cycle synchronization would also translate to an improved KI efficiency when combined with 316 our transient antibiotic selection. However, in comparison to these previous reports, the method 317 described here is already highly efficient, technically simpler, requires less manipulation, and 318 can be adapted by any lab with a basic cell culture facility. Plasmid design 322 We used the following gRNAs for targeting their respective loci (5'-3', PAM sequence in bold)
The gRNA sequences were based on our prior publications (11, 12) 
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The following donor vectors were used in this study: to a total volume of 48 µL. For transfection tests, Cas9-P2A-mKate2 or lenti-CMV-eGFP (9 kb) 414 plasmids were used. Cas9-P2A-mKate2 was modified from PX458 (Addgene #48138) by replacing GFP with mKate2. Transfection mix was prepared by adding 2 µL of DNA-In Stem 416 (GST-2130, MTI-GlobalStem) to the DNA+Opti-MEM mix from above. The mix was incubated 417 for 10 minutes at room temperature before distributing it to the cells. The next day the cells were 418 fed with fresh media. At ~40 hours after transfection, the cells were selected with 0.5-1.0 µg/mL 419 of puromycin for 24 hours. Following selection, the cells were allowed to recover for 5-7 days 420 and then passaged as 500-1000 single cells per well of a 6 well plate for colony formation. These 421 cells were maintained for 7-10 days before colony picking and PCR analysis.
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Mouse stem cells: 424 mESCs were passaged and plated as 100K per well of a 6 well plate the day before transfection.
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The following day, (for one well) 1 µg of all-in-one Cas9 plasmid and 2 µg of donor plasmid 426 were combined with Opti-MEM to a total volume of 145 µL. After mixing, 5 µL of DNA-In 427 Stem were added to the solution for a 15 minute incubation at room temperature before 428 distribution to a plate well. 24 hours after transfection the cells were selected with 3 µg/mL of 429 puromycin for 24 hours. Following selection, the cells were allowed to recover for 1 day and 430 then passaged as 750 single cells per well of a 6 well plate for colony formation. These cells 431 were maintained for 5 days before colony picking and PCR analysis A homozygous BRN3B-P2A-tdTomato-P2A-Thy1.2 reporter clone was isolated from EP1 hiPSCs 458 and differentiated to RGCs using our previously published protocol(11).
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Mouse:
